Tapentadol, sold under the brand names Nucynta and Palexia among others, is a synthetic opioid analgesic with a dual mode of action as a highly selective full agonist of the μ-opioid receptor and as a
75 mg Nucynta (tapentadol) tablets
Palexia IR 50mg with Australian "controlled drug" warning
Grünenthal GmbH is a German pharmaceutical company headquartered in Aachen in Germany. It was founded in 1946 as Chemie Grünenthal and has been continuously family-owned. The company was the first to
Tapentadol
…Calculator estimates a conversion rate of 50mg of tapentadol equaling 10 mg of oral oxycodone in terms of opioid receptor activation. In the late 1980s, Grünenthal developed tapentadol to improve on tramadol, which they had created in 1962. Their goal was to design a molecule that minimized serotonin activity…
Headquarters of Grünenthal
former headquarters in Stolberg
Permission for Grünenthal to produce penicillin, dated 23 February 1948
Cases of severe phocomelia induced by Thalidomide